MARINE PRODUCTS CORP 8-K

What Happened
Marine Products Corporation filed a Current Report on Form 8‑K on May 1, 2026 to supplement its definitive proxy statement for the proposed stock‑and‑cash combination with MasterCraft Boat Holdings. The Merger Agreement was signed February 5, 2026 and contemplates a two‑step merger (Merger Sub I into Marine Products, then Marine Products into Merger Sub II). Marine Products filed the definitive proxy on April 2, 2026 and began mailing it on April 6, 2026 for a special stockholder meeting scheduled for May 12, 2026. After receiving demand letters and two lawsuits filed April 22, 2026 in New York (Jones v. Marine Products, No. 652386/2026; Morgan v. Marine Products, No. 652434/2026) alleging misleading proxy disclosures, Marine Products denies the allegations but voluntarily supplemented the proxy to moot the claims without admitting liability. The board continues to unanimously recommend voting “FOR” the merger and related proposals.

Key Details

• Merger structure: Agreement dated Feb 5, 2026; two-step merger where Marine Products becomes a wholly owned subsidiary of MasterCraft.
• Proxy timing: S‑4 declared effective March 27, 2026; definitive joint proxy/prospectus mailed April 6, 2026; special meeting set for May 12, 2026.
• Litigation & response: Demand letters and two NY state complaints filed Apr 22, 2026 alleging negligence/negligent misrepresentation; Marine Products supplemented its proxy disclosures to moot the claims while denying liability.
• Updated financial disclosures: MasterCraft DCF implied equity value per share of $35.16–$38.80 (compared to MasterCraft close $23.12 on Feb 4, 2026) with MasterCraft net cash ≈ $81.4M; Marine Products analyses showed implied ranges including $9.50–$10.54 and $13.00–$14.59 (compared to Marine Products close $9.94 on Feb 4, 2026). Selected public comp shown: Malibu Boats EV $670M (9.5x/9.1x adj. EBITDA).

Why It Matters
This 8‑K update matters to investors because it (1) confirms the Merger timeline and upcoming shareholder vote, (2) discloses that litigation has been filed challenging the proxy and that the company chose to supplement disclosures to avoid further dispute, and (3) provides advisor valuation details and conflicts (e.g., Truist revenue disclosures and valuation assumptions) that underpin the transaction rationale. The board’s unanimous support and the S‑4 effectiveness mean the vote proceeds as scheduled, but the litigation and any further challenges could affect timing, costs, or outcomes. Investors should review the supplemental proxy, the joint proxy/prospectus, and the complaint filings for full details before voting or trading.